Jan Roland Lambrecht
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jan Roland Lambrecht has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
A Vaktskjold
Department of Gastroenterological Surgery, Sykehuset Innlandet Hospital Trust, Gjøvik, Norway
1 shared publicationA. Vaktskjold
Dep. of Sports and Active Lifestyle, Hoyskolen i Hedmark, Elevrum, Norway
1 shared publicationArild Vaktskjold
Surgical Department; Sykehuset Innlandet Health Trust; Brumunddal Norway
1 shared publication- Arild Vaktskjold
Hedmark University of Applied Sciences, Elverum, Norway (Department of Public Health).
1 shared publication - Benjamin K. Poulose
Center for Abdominal Core Health, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, USA
1 shared publication - Björn Törnqvist
Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet , Stockholm
1 shared publication
Latest Publications
- Open Access
- 19 September 2026
- Published by SAGE Publications in Scandinavian Journal of Surgery
The Nordic parastomal hernia paradox: A regional survey of prophylaxis and repair
Background and aims: To evaluate current preferences and practices as well as institutional policies regarding parastomal hernia (PSH) prevention and repair among Nordic surgeons. Methods: A cross-sectional, web-based survey was distributed to consultant-level surgeons and senior trainees across Denmark, Finland, Norway, and Sweden, assessing demographics, prophylaxis practices, and repair preferences. Results: A total of 191 surgeons responded, of whom 98% practiced in academic or regional hospitals and 50% had >10 years of specialist experience. Among the 166 respondents (87%) who performed permanent end colostomies, only 28% currently used prophylactic mesh, while 53% had never used it, and 19% had discontinued prior use. Prophylactic adoption varied markedly by country: Finland (81%) versus Denmark (0%). Primary barriers were belief in acceptable non-mesh outcomes (42%) and complication fears (40%). Among current mesh users, the intraperitoneal funnel (Chimney) technique was most prevalent (54%). For PSH repair (n = 111), laparoscopic Sugarbaker was the most frequently performed (41%) and preferred (34%) technique. Robotic Pauli emerged as the second most preferred approach (20%), and robotic-assisted repair was used by 17% of repair-performing surgeons, but preferred by 39% of hernia/abdominal wall reconstruction (AWR) specialists. Open surgery was used by 50% but preferred by only 20%, reflecting a marked preference-utilization gap. One-third of respondents (36%) believed more patients should be offered elective PSH repair, with significant country-level variation: 65% of Swedish surgeons favored more repairs, while 42% of Danish surgeons favored fewer repairs. Conclusion: A substantial implementation gap in PSH prophylaxis persists across the Nordic region, driven by surgical culture rather than evidence. In contrast, repair practice is shifting decisively toward robotic retromuscular techniques, led by specialists. The perceived need for more elective repairs, particularly given the high mortality (up to 29%) of emergency repair, supports adopting centralized referral pathways—modeled on the Danish experience—to improve regional outcomes.
- 19 September 2026
- Published by SAGE Publications in Scandinavian Journal of Surgery
Open AccessThe Nordic parastomal hernia paradox: A regional survey of prophylaxis and repair
Background and aims: To evaluate current preferences and practices as well as institutional policies regarding parastomal hernia (PSH) prevention and repair among Nordic surgeons. Methods: A cross-sectional, web-based survey was distributed to consultant-level surgeons and senior trainees across Denmark, Finland, Norway, and Sweden, assessing demographics, prophylaxis practices, and repair preferences. Results: A total of 191 surgeons responded, of whom 98% practiced in academic or regional hospitals and 50% had >10 years of specialist experience. Among the 166 respondents (87%) who performed permanent end colostomies, only 28% currently used prophylactic mesh, while 53% had never used it, and 19% had discontinued prior use. Prophylactic adoption varied markedly by country: Finland (81%) versus Denmark (0%). Primary barriers were belief in acceptable non-mesh outcomes (42%) and complication fears (40%). Among current mesh users, the intraperitoneal funnel (Chimney) technique was most prevalent (54%). For PSH repair (n = 111), laparoscopic Sugarbaker was the most frequently performed (41%) and preferred (34%) technique. Robotic Pauli emerged as the second most preferred approach (20%), and robotic-assisted repair was used by 17% of repair-performing surgeons, but preferred by 39% of hernia/abdominal wall reconstruction (AWR) specialists. Open surgery was used by 50% but preferred by only 20%, reflecting a marked preference-utilization gap. One-third of respondents (36%) believed more patients should be offered elective PSH repair, with significant country-level variation: 65% of Swedish surgeons favored more repairs, while 42% of Danish surgeons favored fewer repairs. Conclusion: A substantial implementation gap in PSH prophylaxis persists across the Nordic region, driven by surgical culture rather than evidence. In contrast, repair practice is shifting decisively toward robotic retromuscular techniques, led by specialists. The perceived need for more elective repairs, particularly given the high mortality (up to 29%) of emergency repair, supports adopting centralized referral pathways—modeled on the Danish experience—to improve regional outcomes.
- Open Access
- 4 September 2026
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 10 (5)
International expert consensus on managing elective hernia repair in patients with Crohn’s disease using the Delphi method
Background: Patients with Crohn’s disease (CD) may be predisposed to mesh-related complications such as impaired wound healing and fistula formation following hernia repair. With limited evidence and no established guidelines for hernia repair in CD, this Delphi study aimed to establish a hernia expert consensus on elective inguinal, incisional, and parastomal hernia repair in patients with CD. Methods: A three-round Delphi process including 21 hernia experts from Europe and the USA was conducted between 24 April and 15 October 2025. The primary outcome of interest was a consensus ≥ 75% among participants. Near consensus was defined as ≥ 70% agreement. Statements were developed from participant comments and questionnaire responses. Experts evaluated statements on timing, surgical approach, and mesh selection (synthetic non-absorbable, synthetic absorbable, biosynthetic, biological, and non-mesh) across different CD subtypes in elective inguinal, incisional, and parastomal hernia repair. Patients were categorized into three CD subtypes, namely abdominal fistulizing Crohn's disease (FCD), isolated perianal FCD, and non-FCD, with each assessed in both active and non-active inflammatory disease states. Results: Consensus or near consensus was achieved for 12 of 20 items (60%) in Round 1, 17 of 33 items (52%) in Round 2, and 13 of 29 items (45%) in Round 3. Overall, 42 of 72 unique items reached consensus (34 items) or near consensus (8 items). It was suggested that elective hernia repair should be avoided in CD patients with active inflammation, regardless of abdominal FCD or non-FCD. In non-active CD, synthetic non-absorbable mesh was suggested for inguinal, incisional, and parastomal hernia repair. Standard mesh placement was recommended for inguinal hernias, whereas retromuscular or preperitoneal mesh placement was recommended for incisional and parastomal hernias. No consensus was reached to avoid elective repair in isolated perianal FCD with active inflammation. The use of non-mesh repair, synthetic absorbable, biological, or biosynthetic mesh was generally not recommended in the elective setting. Conclusions: Consensus was reached that CD with non-active inflammation does not require deviation from standard hernia repair principles provided that the mesh is positioned in extraperitoneal positions. However, patients with CD may have an increased perioperative risk and the surgical management should be guided by shared decision-making.
- 4 September 2026
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 10 (5)
Open AccessInternational expert consensus on managing elective hernia repair in patients with Crohn’s disease using the Delphi method
Background: Patients with Crohn’s disease (CD) may be predisposed to mesh-related complications such as impaired wound healing and fistula formation following hernia repair. With limited evidence and no established guidelines for hernia repair in CD, this Delphi study aimed to establish a hernia expert consensus on elective inguinal, incisional, and parastomal hernia repair in patients with CD. Methods: A three-round Delphi process including 21 hernia experts from Europe and the USA was conducted between 24 April and 15 October 2025. The primary outcome of interest was a consensus ≥ 75% among participants. Near consensus was defined as ≥ 70% agreement. Statements were developed from participant comments and questionnaire responses. Experts evaluated statements on timing, surgical approach, and mesh selection (synthetic non-absorbable, synthetic absorbable, biosynthetic, biological, and non-mesh) across different CD subtypes in elective inguinal, incisional, and parastomal hernia repair. Patients were categorized into three CD subtypes, namely abdominal fistulizing Crohn's disease (FCD), isolated perianal FCD, and non-FCD, with each assessed in both active and non-active inflammatory disease states. Results: Consensus or near consensus was achieved for 12 of 20 items (60%) in Round 1, 17 of 33 items (52%) in Round 2, and 13 of 29 items (45%) in Round 3. Overall, 42 of 72 unique items reached consensus (34 items) or near consensus (8 items). It was suggested that elective hernia repair should be avoided in CD patients with active inflammation, regardless of abdominal FCD or non-FCD. In non-active CD, synthetic non-absorbable mesh was suggested for inguinal, incisional, and parastomal hernia repair. Standard mesh placement was recommended for inguinal hernias, whereas retromuscular or preperitoneal mesh placement was recommended for incisional and parastomal hernias. No consensus was reached to avoid elective repair in isolated perianal FCD with active inflammation. The use of non-mesh repair, synthetic absorbable, biological, or biosynthetic mesh was generally not recommended in the elective setting. Conclusions: Consensus was reached that CD with non-active inflammation does not require deviation from standard hernia repair principles provided that the mesh is positioned in extraperitoneal positions. However, patients with CD may have an increased perioperative risk and the surgical management should be guided by shared decision-making.
- 3 September 2024
- Published by Springer Nature in Surgical Endoscopy
- Vol. 38 (10) , 6161-6168
Robotic Pauli repair of parastomal hernia
Background Robotic retro-muscular mesh repair of parastomal hernia (PH) is possible with transversus abdominis release. The aim of this study is to report mid-term results with this method. Methods Patients who underwent surgery for PH were enrolled in a prospective study. Patients with concomitant midline hernia also underwent Rives repair. Polypropylene meshes with an absorbable buffer mesh were used in the retro-muscular pocket—except PTFE was chosen for inflammatory bowel disease patients. Follow-up was by telephone and physical examination and CT if suspicion of complication. Results Of the 56 included ostomy patients, 44 had colostomies, 10 had ileostomies, and two had urostomies. Thirty-nine percent had a concomitant hernia, and 25% had recurrent PH. The mean operating time without accessory repair was 156 min (SD 37), and with accessory repairs 220 min (SD 62). One bowel lesion and one vascular injury to the stoma occurred, prompting intraoperative stoma revision without postoperative morbidity. Postoperative complications ensued in 12 patients (23%). One patient had stoma necrosis after 3 weeks and the stoma was relocated. One patient had a mesh infection, 3 patients temporary ileus, one patient hypovolemic renal failure, and two patients experienced a flare-up of their Crohn’s Disease. One parastomal abscess was drained percutaneously. The median postoperative stay was 3 days (1–21; mean 3.7 days), and the readmission rate was 8.9%. The recurrence rate at mean and median 24 months follow-up is 5.4%, two in ileostomy patients and one colostomy patient with unaltered bulging where CT shows a relatively large prolapse and recorded as a failure. Conclusion Robotic Pauli repair has shown promising results. However, repair fails of PH at small bowel ostomies with short mesentery. ePauli/TAR is now the preliminary choice for eligible patients at our site. Comparative studies with the intraperitoneal mesh standard are needed.
- 3 September 2024
- Published by Springer Nature in Surgical Endoscopy
- Vol. 38 (10) , 6161-6168
Robotic Pauli repair of parastomal hernia
Background Robotic retro-muscular mesh repair of parastomal hernia (PH) is possible with transversus abdominis release. The aim of this study is to report mid-term results with this method. Methods Patients who underwent surgery for PH were enrolled in a prospective study. Patients with concomitant midline hernia also underwent Rives repair. Polypropylene meshes with an absorbable buffer mesh were used in the retro-muscular pocket—except PTFE was chosen for inflammatory bowel disease patients. Follow-up was by telephone and physical examination and CT if suspicion of complication. Results Of the 56 included ostomy patients, 44 had colostomies, 10 had ileostomies, and two had urostomies. Thirty-nine percent had a concomitant hernia, and 25% had recurrent PH. The mean operating time without accessory repair was 156 min (SD 37), and with accessory repairs 220 min (SD 62). One bowel lesion and one vascular injury to the stoma occurred, prompting intraoperative stoma revision without postoperative morbidity. Postoperative complications ensued in 12 patients (23%). One patient had stoma necrosis after 3 weeks and the stoma was relocated. One patient had a mesh infection, 3 patients temporary ileus, one patient hypovolemic renal failure, and two patients experienced a flare-up of their Crohn’s Disease. One parastomal abscess was drained percutaneously. The median postoperative stay was 3 days (1–21; mean 3.7 days), and the readmission rate was 8.9%. The recurrence rate at mean and median 24 months follow-up is 5.4%, two in ileostomy patients and one colostomy patient with unaltered bulging where CT shows a relatively large prolapse and recorded as a failure. Conclusion Robotic Pauli repair has shown promising results. However, repair fails of PH at small bowel ostomies with short mesentery. ePauli/TAR is now the preliminary choice for eligible patients at our site. Comparative studies with the intraperitoneal mesh standard are needed.
- Open Access
- 4 June 2024
- Published by Springer Nature in Research Square
Robotic Pauli repair of parastomal hernia
Background Robotic retro-muscular mesh repair of parastomal hernia (PH) is possible with transversus abdominis release. The aim of this study is to report mid-term results with this method. Methods Patients who underwent surgery for PH were enrolled in a prospective study. Patients with concomitant midline hernia also underwent Rives repair. Polypropylene meshes with an absorbable buffer mesh were used in the retro-muscular pocket – except PTFE was chosen for inflammatory bowel disease patients. Results Of the 53 included ostomy patients, 43 had colostomies, 8 had ileostomies, and 2 had urostomies, all of which were of the end type. Forty percent had a concomitant hernia, and 26% had recurrent PH. The mean operating time without accessory repair was 156 minutes (SD 37), and that with accessory repairs was 220 minutes (SD 62). Postoperative complications ensued in 12 patients (23%). One bowel lesion and one vascular injury to the stoma occurred, prompting intraoperative revision of the stoma without postoperative morbidity. One patient had late stoma necrosis and was relocated after 3 weeks. One patient had a mesh infection, 3 patients suffered temporary ileus, one patient experienced hypovolemic renal failure, and one of two patients experienced a flare-up of their IBD. One parastomal abscess was removed with a percutaneous drain. The median postoperative stay was 3 days (1–21; mean 3.7 days), and the readmission rate was 7.5%. The recurrence rate at mean and median 24 months follow up is 3.8%, both in ileostomy patients. Conclusions Robotic Pauli repair has shown promising results. However, repair fails of PH at small bowel ostomies with short mesentery. ePauli/TAR is now the standard operation for all eligible patients at our site.
- 4 June 2024
- Published by Springer Nature in Research Square
Open AccessRobotic Pauli repair of parastomal hernia
Background Robotic retro-muscular mesh repair of parastomal hernia (PH) is possible with transversus abdominis release. The aim of this study is to report mid-term results with this method. Methods Patients who underwent surgery for PH were enrolled in a prospective study. Patients with concomitant midline hernia also underwent Rives repair. Polypropylene meshes with an absorbable buffer mesh were used in the retro-muscular pocket – except PTFE was chosen for inflammatory bowel disease patients. Results Of the 53 included ostomy patients, 43 had colostomies, 8 had ileostomies, and 2 had urostomies, all of which were of the end type. Forty percent had a concomitant hernia, and 26% had recurrent PH. The mean operating time without accessory repair was 156 minutes (SD 37), and that with accessory repairs was 220 minutes (SD 62). Postoperative complications ensued in 12 patients (23%). One bowel lesion and one vascular injury to the stoma occurred, prompting intraoperative revision of the stoma without postoperative morbidity. One patient had late stoma necrosis and was relocated after 3 weeks. One patient had a mesh infection, 3 patients suffered temporary ileus, one patient experienced hypovolemic renal failure, and one of two patients experienced a flare-up of their IBD. One parastomal abscess was removed with a percutaneous drain. The median postoperative stay was 3 days (1–21; mean 3.7 days), and the readmission rate was 7.5%. The recurrence rate at mean and median 24 months follow up is 3.8%, both in ileostomy patients. Conclusions Robotic Pauli repair has shown promising results. However, repair fails of PH at small bowel ostomies with short mesentery. ePauli/TAR is now the standard operation for all eligible patients at our site.
- Open Access
- 20 July 2021
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (9) , 5397
Correction to: Endoscopic preperitoneal parastomal hernia repair (ePauli repair): an observational study
- 20 July 2021
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (9) , 5397
Open AccessCorrection to: Endoscopic preperitoneal parastomal hernia repair (ePauli repair): an observational study
- Open Access
- 4 January 2021
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (4) , 1903-1907
Endoscopic preperitoneal parastomal hernia repair (ePauli repair) : an observational study
Background: Aspiring endoscopic surgery with extraperitoneal mesh application to avoid adhesion and pain from mesh fixation, we adopted the principles of the open Pauli repair of parastomal hernia (PSH). We have termed the procedure ePauli repair. The aim of this account is to inform about feasibility and adverse reactions. Methods: Patients with PSH selected for ePauli repair with transversus abdominis release (TAR) were enrolled in a prospective observational study. Patients were operated with laparoscopic or robotic assistance and endoscopic Rives-Stoppa repair in cases with concomitant midline hernia. Coated meshes or a buffer mesh was used in the retromuscular pocket for this modification of the Sugarbaker principle. Results: Fifteen patients were included: six patients were operated laparoscopically and nine patients with robotic assistance. The median age of the stomas was 33 months (7–313). Five PSHs were recurrent after previous repairs. Median operating time without midline hernia repair was 156 min (107–233) and with midline hernia repair 241 min (176–286). One serosa lesion arose during operation, prompting intraoperative revision of the ostomy without postoperative morbidity. Two patients had postoperative obstruction and were readmitted to operation: one with multiple adhesions and one had kinking of the stoma bowel caused by insufficient incision of the transversalis fascia. No infections or seromas have been observed. One patient had discoloring of the flank with spontaneous remission, and one patient had recurrence. Median postoperative admission time was 3 days (1–19). Median follow-up is 10 months (0–27). Conclusions: ePauli repair is technically challenging but feasible. With our limited experience, we are encouraged with the pain, complication, and functional summary after ePauli repair and hopeful for the recurrence profile. ePauli/TAR is not for every patient or every surgeon and whether it should be restrained to recurrent PSH or be offered as first-line treatment for PSH is disputable.
- 4 January 2021
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (4) , 1903-1907
Open AccessEndoscopic preperitoneal parastomal hernia repair (ePauli repair) : an observational study
Background: Aspiring endoscopic surgery with extraperitoneal mesh application to avoid adhesion and pain from mesh fixation, we adopted the principles of the open Pauli repair of parastomal hernia (PSH). We have termed the procedure ePauli repair. The aim of this account is to inform about feasibility and adverse reactions. Methods: Patients with PSH selected for ePauli repair with transversus abdominis release (TAR) were enrolled in a prospective observational study. Patients were operated with laparoscopic or robotic assistance and endoscopic Rives-Stoppa repair in cases with concomitant midline hernia. Coated meshes or a buffer mesh was used in the retromuscular pocket for this modification of the Sugarbaker principle. Results: Fifteen patients were included: six patients were operated laparoscopically and nine patients with robotic assistance. The median age of the stomas was 33 months (7–313). Five PSHs were recurrent after previous repairs. Median operating time without midline hernia repair was 156 min (107–233) and with midline hernia repair 241 min (176–286). One serosa lesion arose during operation, prompting intraoperative revision of the ostomy without postoperative morbidity. Two patients had postoperative obstruction and were readmitted to operation: one with multiple adhesions and one had kinking of the stoma bowel caused by insufficient incision of the transversalis fascia. No infections or seromas have been observed. One patient had discoloring of the flank with spontaneous remission, and one patient had recurrence. Median postoperative admission time was 3 days (1–19). Median follow-up is 10 months (0–27). Conclusions: ePauli repair is technically challenging but feasible. With our limited experience, we are encouraged with the pain, complication, and functional summary after ePauli repair and hopeful for the recurrence profile. ePauli/TAR is not for every patient or every surgeon and whether it should be restrained to recurrent PSH or be offered as first-line treatment for PSH is disputable.
- 8 May 2020
- Published by Wolters Kluwer Health in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
- Vol. 30 (4) , 345-350
Mini-invasive Surgery and Parastomal Hernia: Higher Frequency and No Prophylactic Mesh Effect
Aim: Parastomal hernia (PSH) is very common. Recent reports suggest increased frequency after laparoscopic stoma formation compared with open surgery. A retrospective chart review was designed to appraise the outcomes regarding PSH in open and in laparoscopic procedures. Materials and Methods: All patients operated by rectal resection and planned end-colostomy in the period from 2004 to 2018 were reviewed. A total of 70 open and 101 laparoscopic operations were identified. A modified retromuscular mesh application through the trephine was used for the prevention of PSH in 42% of patients in the laparoscopic group. Results: The median follow-up was 58 (1 to 167) months in the open group and 43 (0 to 153) months in the laparoscopic group. Patient characteristics were evenly distributed between the groups, except for more male patients and higher American Society of Anesthesiologists Score as well as higher rates of patients with neoadjuvant treatment and mesh prophylaxis, in the laparoscopic group. Clinical PSH occurrences were 2 (3%) in the open group and 18 (18%) in the laparoscopic group (P=0.00). Propensity-weighted analysis estimates increased odds ratio (OR) for PSH in the laparoscopic group [OR=11.8; 95% confidence interval (CI): 1.4-96.6]. PSH repair rates were 0 in the open group and 6/18 (33%) in the laparoscopic group. Mesh prophylaxis in the laparoscopic group did not influence PSH outcome (OR=1.4; 95% CI: 0.5-4.0). Computed tomography scans were assessable in 48 and 66 patients, with median follow-up timepoints of 42 and 30 months in the open and laparoscopic groups, respectively, and 8 (18%) and 21 patients (32%) were diagnosed with PSH. Computed tomography assessment implied an increased risk for PSH in laparoscopy (OR=3.5; 95% CI: 1.1-11.9). Aggregate of chart and computed tomography occurrence of PSH showed an equivalent hazard (OR=3.2; 95% CI: 1.1-9.5). Interpretations: Laparoscopic operations with stoma formation seem to have an increased rate of PSH in comparison with open operations and the results support previous claims. Retromuscular keyhole mesh placement may not be the ideal method of PSH prevention in laparoscopic stoma formation.
- 8 May 2020
- Published by Wolters Kluwer Health in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
- Vol. 30 (4) , 345-350
Mini-invasive Surgery and Parastomal Hernia: Higher Frequency and No Prophylactic Mesh Effect
Aim: Parastomal hernia (PSH) is very common. Recent reports suggest increased frequency after laparoscopic stoma formation compared with open surgery. A retrospective chart review was designed to appraise the outcomes regarding PSH in open and in laparoscopic procedures. Materials and Methods: All patients operated by rectal resection and planned end-colostomy in the period from 2004 to 2018 were reviewed. A total of 70 open and 101 laparoscopic operations were identified. A modified retromuscular mesh application through the trephine was used for the prevention of PSH in 42% of patients in the laparoscopic group. Results: The median follow-up was 58 (1 to 167) months in the open group and 43 (0 to 153) months in the laparoscopic group. Patient characteristics were evenly distributed between the groups, except for more male patients and higher American Society of Anesthesiologists Score as well as higher rates of patients with neoadjuvant treatment and mesh prophylaxis, in the laparoscopic group. Clinical PSH occurrences were 2 (3%) in the open group and 18 (18%) in the laparoscopic group (P=0.00). Propensity-weighted analysis estimates increased odds ratio (OR) for PSH in the laparoscopic group [OR=11.8; 95% confidence interval (CI): 1.4-96.6]. PSH repair rates were 0 in the open group and 6/18 (33%) in the laparoscopic group. Mesh prophylaxis in the laparoscopic group did not influence PSH outcome (OR=1.4; 95% CI: 0.5-4.0). Computed tomography scans were assessable in 48 and 66 patients, with median follow-up timepoints of 42 and 30 months in the open and laparoscopic groups, respectively, and 8 (18%) and 21 patients (32%) were diagnosed with PSH. Computed tomography assessment implied an increased risk for PSH in laparoscopy (OR=3.5; 95% CI: 1.1-11.9). Aggregate of chart and computed tomography occurrence of PSH showed an equivalent hazard (OR=3.2; 95% CI: 1.1-9.5). Interpretations: Laparoscopic operations with stoma formation seem to have an increased rate of PSH in comparison with open operations and the results support previous claims. Retromuscular keyhole mesh placement may not be the ideal method of PSH prevention in laparoscopic stoma formation.
- 28 March 2020
- Published by Springer Nature in Hernia
- Vol. 25 (3) , 817-820
Diagnostic methods in parastomal hernia; research and clinical relevance
- 28 March 2020
- Published by Springer Nature in Hernia
- Vol. 25 (3) , 817-820
Diagnostic methods in parastomal hernia; research and clinical relevance
- Open Access
- 11 September 2015
- Published by Wiley in Colorectal Disease
- Vol. 17 (10) , O191-7
Prophylactic mesh at end‐colostomy construction reduces parastomal hernia rate: a randomized trial
Aim: Parastomal hernia (PSH) is the most common complication of an end‐colostomy and about one‐quarter of patients need operative repair, which is often unsuccessful. A randomized trial was carried out to compare the results of using mesh or no mesh at the time of formation of a colostomy with the clinical identification of PSH as the primary outcome.Method: In this two‐centre randomized trial (Oslo University Hospital and Sykehuset Innlandet Hospital Trust, Norway), patients with rectal cancer undergoing open pelvic surgery were randomized to receive a retromuscular synthetic mesh (study group, n = 32) or no mesh (control group, n = 26) at the time of end‐colostomy formation. Postoperative follow up was not blinded and included clinical examination and routine CT.Results: The median period of follow up was 40 (range: 84) months. There were no differences in demographic variables or complications between the study and control groups. PSH developed in two patients of the study group and in 12 of the control group [OR = 0.04 (95% CI: 0.01–0.30) and hazard ratio 0.134 (95% CI: 0.030–0.603); P < 0.001]. The number needed to treat to avoid one PSH was 2.5 patients. CT demonstrated an increase over time in the size of the fascial orifice in patients with PSH without mesh prophylaxis, in contrast to a stable size in patients with mesh and in the control patients who did not develop PSH.Conclusion: The retromuscular insertion of synthetic mesh at the time of formation of an end‐colostomy reduced the risk of PSH.
- 11 September 2015
- Published by Wiley in Colorectal Disease
- Vol. 17 (10) , O191-7
Open AccessProphylactic mesh at end‐colostomy construction reduces parastomal hernia rate: a randomized trial
Aim: Parastomal hernia (PSH) is the most common complication of an end‐colostomy and about one‐quarter of patients need operative repair, which is often unsuccessful. A randomized trial was carried out to compare the results of using mesh or no mesh at the time of formation of a colostomy with the clinical identification of PSH as the primary outcome.Method: In this two‐centre randomized trial (Oslo University Hospital and Sykehuset Innlandet Hospital Trust, Norway), patients with rectal cancer undergoing open pelvic surgery were randomized to receive a retromuscular synthetic mesh (study group, n = 32) or no mesh (control group, n = 26) at the time of end‐colostomy formation. Postoperative follow up was not blinded and included clinical examination and routine CT.Results: The median period of follow up was 40 (range: 84) months. There were no differences in demographic variables or complications between the study and control groups. PSH developed in two patients of the study group and in 12 of the control group [OR = 0.04 (95% CI: 0.01–0.30) and hazard ratio 0.134 (95% CI: 0.030–0.603); P < 0.001]. The number needed to treat to avoid one PSH was 2.5 patients. CT demonstrated an increase over time in the size of the fascial orifice in patients with PSH without mesh prophylaxis, in contrast to a stable size in patients with mesh and in the control patients who did not develop PSH.Conclusion: The retromuscular insertion of synthetic mesh at the time of formation of an end‐colostomy reduced the risk of PSH.
- 7 February 2015
- Published by Springer Nature in Hernia
- Vol. 19 (3) , 479-486
Laparoscopic ventral hernia repair: outcomes in primary versus incisional hernias: no effect of defect closure
Supposing divergent aetiology, we found it interesting to investigate outcomes between primary (PH) versus incisional (IH) hernias. In addition, we wanted to analyse the effect of defect closure and mesh fixation techniques. 37 patients with PH and 70 with IH were enrolled in a prospective cohort-study, treated with laparoscopic ventral hernia repair (LVHR) and randomised to ± transfascial sutures. In addition, we analysed results from a retrospective study with 36 PH and 51 IH patients. Mean follow-up time was 38 months in the prospective study and 27 months in the retrospective study. 35 % of PH’s and 10 % of IH’s were recurrences after previous suture repair. No late infections or mesh removals occurred. Recurrence rates in the prospective study were 0 vs. 4.3 % (p = 0.55) and the complication rates were 16 vs. 27 % (p = 0.24) in favour of the PH cohort. The IH group had a mesh protrusion rate of 13 vs. 5 % in the PH group (p = 0.32), and significantly (p < 0.01) larger hernias and adhesion score, longer operating time (100 vs. 79 min) and admission time (2.8 vs. 1.6 days). Closure of the hernia defect did not influence rate of seroma, pain at 2 months, protrusion or recurrence. An overall increased complication rate was seen after defect closure (OR 3.42; CI 1.25–9.33). With PH, in comparison to IH treated with LVHR, no differences were observed regarding recurrence, protrusion or complication rates. Defect closure (raphe), when using absorbable suture, did not benefit long-term outcomes and caused a higher overall complication rate. (ClinicalTrials.gov number: NCT00455299).
- 7 February 2015
- Published by Springer Nature in Hernia
- Vol. 19 (3) , 479-486
Laparoscopic ventral hernia repair: outcomes in primary versus incisional hernias: no effect of defect closure
Supposing divergent aetiology, we found it interesting to investigate outcomes between primary (PH) versus incisional (IH) hernias. In addition, we wanted to analyse the effect of defect closure and mesh fixation techniques. 37 patients with PH and 70 with IH were enrolled in a prospective cohort-study, treated with laparoscopic ventral hernia repair (LVHR) and randomised to ± transfascial sutures. In addition, we analysed results from a retrospective study with 36 PH and 51 IH patients. Mean follow-up time was 38 months in the prospective study and 27 months in the retrospective study. 35 % of PH’s and 10 % of IH’s were recurrences after previous suture repair. No late infections or mesh removals occurred. Recurrence rates in the prospective study were 0 vs. 4.3 % (p = 0.55) and the complication rates were 16 vs. 27 % (p = 0.24) in favour of the PH cohort. The IH group had a mesh protrusion rate of 13 vs. 5 % in the PH group (p = 0.32), and significantly (p < 0.01) larger hernias and adhesion score, longer operating time (100 vs. 79 min) and admission time (2.8 vs. 1.6 days). Closure of the hernia defect did not influence rate of seroma, pain at 2 months, protrusion or recurrence. An overall increased complication rate was seen after defect closure (OR 3.42; CI 1.25–9.33). With PH, in comparison to IH treated with LVHR, no differences were observed regarding recurrence, protrusion or complication rates. Defect closure (raphe), when using absorbable suture, did not benefit long-term outcomes and caused a higher overall complication rate. (ClinicalTrials.gov number: NCT00455299).